Pular para o conteúdo
Merck
HomeWebinarsQualification of Aseptic Filling Lines for Beverage Industry

Qualification of Aseptic Filling Lines for Beverage Industry



WEBINAR

Linden Grain Medium (LGM) is a microbiologically sensitive, nutritive culture medium used for media fill process simulation in beverage bottling. The aim is to test the absence of spoiling organisms in high and low acids beverages.

The webinar explains the principles of aseptic media fill qualifications, the handling of Linden Grain Medium in the qualifications, the usage of LGM and provides practical tips, e.g. for PH adjustments, for optimal sterility test results.

In this webinar, you will learn:

  • Validation of Aseptic PET Filling Lines in the beverage industry
  • Usage of Linden Grain medium for sterility tests in aseptic filling lines in the Beverage industry

Speakers

Andreas Bubert, PhD

Andreas Bubert, PhD

Merck

Senior Product Manager, Culture Media Food & Beverage

Andreas received a PhD in molecular microbiology for his research and diagnostics work on Listeria. He has over 24 years’ experience at Merck focusing on microbiological solutions for the food and beverage industries. He is a member of AOAC RI Advisory Council and has authored over 50 publications. .

Silvia Garulli, Ph.D.

Silvia Garulli, Ph.D.

Sidel, Parma, Italy

Microbiology & Aseptic Laboratories Manager

Dr. Silvia Garulli has a University Degree in Food Science and Technologies. With 18 years’ experience in microbiology, she joined Sidel in 2006, where she is now the manager of Group’s aseptic technologies and microbiology laboratories. Her role entails the management of scientific projects on beverages and on innovative decontamination technologies; Drafting of scientific experimental design for R&D projects; Customer proximity providing trainings and technical support.

Webinar Information

Food and beverage testing and manufacturing

  • Microbiological analysis
  • Duração:1h

  • Idioma:English

  • Sessão 1:apresentado February 17, 2022

    Watch Now


Faça login para continuar

Para continuar lendo, faça login ou crie uma conta.

Ainda não tem uma conta?